Brisbane Diamantina Health Partners

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article contains content that is written like an advertisement. Please help by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (July 2016) (Learn how and when to remove this template message) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help by replacing them with more appropriate citations to reliable, independent, third-party sources. (July 2016) (Learn how and when to remove this template message) This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (May 2016) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Brisbane Diamantina Health Partners (BDHP) is the first Advanced Health Research Translation Centre in Queensland, Australia. The organisation’s purpose is to strengthen the linkages between healthcare, research and education in order to deliver better health outcomes for the community. By encouraging and supporting collaboration, BDHP assists the translation and integration of cutting-edge research and innovation into healthcare delivery.^[1]

BDHP has two main offices: one located within the Translational Research Institute on the Princess Alexandra Hospital campus, the other located within The University of Queensland’s Centre for Clinical Research on the Royal Brisbane and Women’s Hospital campus.

Partners[]

Brisbane Diamantina Health Partners is a collaboration which brings together four hospitals, two universities, two medical research institutes, a primary health care network, and Queensland Health ^[2]

• Mater Health Services
• Metro South Health
• QIMR Berghofer Medical Research Institute
• Queensland University of Technology
• The University of Queensland
• Translational Research Institute
• Queensland Health

The BDHP partner organisations have a combined annual budget of over $7.5billion, servicing and supporting over 3 million patients, researchers and students each year.

History[]

Brisbane Diamantina Health Partners’ history dates back to 2011 with the establishment of the Mayne Health Science Alliance and . In 2014, these two Academic Health Science Centres came together with Children's Health Queensland in a collaborative arrangement to form the Brisbane Diamantina Health Partners Academic Health Science System.,^[1][3][4][5]

Brisbane Diamantina Health Partners is named after Lady Diamantina Bowen. Born in 1833, Lady Bowen initiated and worked for several charities, including the Lady Bowen Lying-In Hospital, the Diamantina Home for Incurables, and the Sisters of Mercy — the Catholic order that established Mater Health Services.

The founding partners were Metro North Hospital and Health Service, Metro South Hospital and Health Service, Children’s Health Queensland Hospital and Health Service, Mater Health Services, The University of Queensland, Queensland University of Technology, the Translational Research Institute and the QIMR Berghofer Medical Research Institute.^[6]

In 2016, the Queensland Department of Health and Brisbane South PHN joined as full partners. In addition, the Southern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care and CSIRO Australian e-Health Research Centre are collaborators.

On June 9, 2017, it was announced Brisbane Diamantina Health Partners had been accredited by the National Health and Medical Research Council as a new Advanced Health Research and Translation Centre.^[7]

BDHP Leadership[]

Each of the BDHP partner organisations have a representative on the BDHP Board.^[8] The current^[when?] Board Members are:

• Dr Robin Mortimer – Chair, Brisbane Diamantina Health Partners
• Dr Stephen Ayre – Executive Director, PAH-QEII Health Network, Metro South Health
• Professor Scott Bell – Research, Executive Director, Metro North Hospital and Health Service
• Ms Fionnagh Dougan – Health Service Chief Executive, Children’s Health Queensland
• Professor Robyn Ward – Deputy Vice-Chancellor(Research), Faculty of Medicine and Biomedical Sciences, The University of Queensland
• Professor Frank Gannon – Chief Executive Officer and Director, QIMR Berghofer Medical Research Institute
• Dr Shane Kelly – Chief Executive Officer, Mater Health Services
• Professor Carolyn Mountford – Chief Executive Officer, Translational Research Institute
• Professor Ross Young – Executive Dean, Faculty of Health, Queensland University of Technology
• Mr Michael Walsh - Director General, Department of Health, Queensland Government
• Ms Sue Scheinpflug - Chief Executive Officer, Brisbane South PHN
• Ms Areti Gavrilidis - General Manager, Brisbane Diamantina Health Partners

Clinical Themes[]

Through a series of consultations and workshops, Brisbane Diamantina Health Partners established nine broad key clinical themes:

• Ageing
• Brain and Mental Health
• Cancer
• Skin and Skin Cancers
• Chronic Disease
• Evidence and Innovation in Clinical Care
• Immunity, Inflammation, Infection
• Maternal and Child Health
• Trauma, Critical Care and Recovery

These themes are areas of community need in which BDHP’s network of capabilities allows action and leadership to improve health outcomes. While each theme is managed by a different theme leadership team, their purpose is to facilitate collaboration both within and between the themes.^[1]

Events[]

Brisbane Cancer Conference[]

The BDHP Brisbane Cancer Conference is held annually in December at the Brisbane Convention & Exhibition Centre. With over 500 registrants each year, this is the largest meeting of cancer-related researchers, clinicians, educators and industry in Queensland. It is an opportunity to draw together cancer researchers in Brisbane and Queensland to advance collaborative efforts in cancer research.^[9] The meeting comprises plenary lectures and workshops on recent scientific, technological, nursing and medical advances in the diagnosis and treatment of malignant disease. The BDHP Brisbane Cancer Conference is convened by Professor Ken O’Byrne, Clinical Director of the Cancer and Ageing Research Program.^[10][11]

Metabolic Research Collaborative Meeting[]

The BDHP Metabolic Research Collaborative Meeting is a weekly seminar series held at the Translational Research Institute on the Princess Alexandra Hospital campus. Presentations are given by local, national and international researchers in the areas of diabetic complications, endocrinology, exercise science, gastroenterology, hypertension, metabolic medicine, nursing, nutrition and dietetics, and renal medicine. The weekly seminars are an opportunity to hear about the latest research and encourage greater collaboration within and between research streams. The series is convened by Dr Ingrid Hickman, Director of Research, Department of Nutrition and Dietetics, Princess Alexandra Hospital.

Blood Cancers Group Seminar Series[]

The BDHP Blood Cancers Group Seminar Series is held once a month, alternating between the Translational Research Institute on the Princess Alexandra Hospital campus and the QIMR Berghofer Medical Research Institute on the Royal Brisbane and Women's Hospital campus. Presentations are given by local, national and international researchers, providing an opportunity to hear about the latest research and encourage greater collaboration within and between research streams.^[12] The series is convened by Professor Andrew Perkins, Co-leader of the Blood and Bone Diseases Program, Mater Research Institute – University of Queensland.

Circulating Tumour Cell Symposium[]

The BDHP Circulating Tumour Cell Symposium was a single day event that provided up to date coverage of many aspects of tumour research. The event was co-convened by Professor Colleen Nelson, Executive Director of the Australian Prostate Cancer Research Centre-Queensland, and Professor Rik Thompson, of Queensland University of Technology's Institute of Health and Biomedical Innovation. The symposium was attended by some 130 delegates from Queensland University of Technology, The University of Queensland and Griffith Universities, affiliated research institutes, Qld Health, industry and consumer advocacy group representatives as well as attendees from Victoria, New South Wales, Western Australia and South Australia.^[13]

References[]

External links[]

• Advance Health Research Translation Centre program
• Children’s Health Queensland
• Metro North Hospital and Health Service
• Metro South Health
• Brisbane South PHN